| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.00025 | 1 |